Free Trial
→ The chokepoint supplier behind SpaceX's $1.75 trillion empire (From Behind the Markets) (Ad)tc pixel Free DMAAU Stock Alerts

Drugs Made in America Acquisition (DMAAU) Competitors

Drugs Made in America Acquisition logo
$10.58 +0.15 (+1.44%)
As of 03:30 PM Eastern
Compare

DMAAU vs. ONCHU, ONCHW, ASPCU, AACOU, and ACGCU

Should you be buying Drugs Made in America Acquisition stock or one of its competitors? The main competitors of Drugs Made in America Acquisition include 1RT Acquisition (ONCHU), 1RT Acquisition (ONCHW), A SPAC III Acquisition (ASPCU), Abony Acquisition Corp I (AACOU), and ACP Holdings Acquisition (ACGCU). These companies are all part of the "trading" industry.

How does Drugs Made in America Acquisition compare to 1RT Acquisition?

Drugs Made in America Acquisition (NASDAQ:DMAAU) and 1RT Acquisition (NASDAQ:ONCHU) are both investment offices industry companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, media sentiment, dividends and valuation.

In the previous week, Drugs Made in America Acquisition had 2 more articles in the media than 1RT Acquisition. MarketBeat recorded 2 mentions for Drugs Made in America Acquisition and 0 mentions for 1RT Acquisition. Drugs Made in America Acquisition's average media sentiment score of 0.00 equaled 1RT Acquisition'saverage media sentiment score.

Company Overall Sentiment
Drugs Made in America Acquisition Neutral
1RT Acquisition Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Drugs Made in America AcquisitionN/AN/AN/AN/AN/A
1RT AcquisitionN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Drugs Made in America AcquisitionN/A N/A N/A
1RT Acquisition N/A N/A N/A

Summary

Drugs Made in America Acquisition beats 1RT Acquisition on 1 of the 1 factors compared between the two stocks.

How does Drugs Made in America Acquisition compare to 1RT Acquisition?

1RT Acquisition (NASDAQ:ONCHW) and Drugs Made in America Acquisition (NASDAQ:DMAAU) are both investment offices industry companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, earnings, analyst recommendations, valuation, media sentiment and institutional ownership.

Company Net Margins Return on Equity Return on Assets
1RT AcquisitionN/A N/A N/A
Drugs Made in America Acquisition N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
1RT AcquisitionN/AN/AN/AN/AN/A
Drugs Made in America AcquisitionN/AN/AN/AN/AN/A

In the previous week, Drugs Made in America Acquisition had 2 more articles in the media than 1RT Acquisition. MarketBeat recorded 2 mentions for Drugs Made in America Acquisition and 0 mentions for 1RT Acquisition. 1RT Acquisition's average media sentiment score of 0.00 equaled Drugs Made in America Acquisition'saverage media sentiment score.

Company Overall Sentiment
1RT Acquisition Neutral
Drugs Made in America Acquisition Neutral

Summary

Drugs Made in America Acquisition beats 1RT Acquisition on 1 of the 1 factors compared between the two stocks.

How does Drugs Made in America Acquisition compare to A SPAC III Acquisition?

A SPAC III Acquisition (NASDAQ:ASPCU) and Drugs Made in America Acquisition (NASDAQ:DMAAU) are both finance companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
A SPAC III AcquisitionN/AN/AN/AN/AN/A
Drugs Made in America AcquisitionN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
A SPAC III AcquisitionN/A N/A N/A
Drugs Made in America Acquisition N/A N/A N/A

In the previous week, Drugs Made in America Acquisition had 1 more articles in the media than A SPAC III Acquisition. MarketBeat recorded 2 mentions for Drugs Made in America Acquisition and 1 mentions for A SPAC III Acquisition. A SPAC III Acquisition's average media sentiment score of 0.00 equaled Drugs Made in America Acquisition'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
A SPAC III Acquisition
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Drugs Made in America Acquisition
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Drugs Made in America Acquisition beats A SPAC III Acquisition on 1 of the 1 factors compared between the two stocks.

How does Drugs Made in America Acquisition compare to Abony Acquisition Corp I?

Abony Acquisition Corp I (NASDAQ:AACOU) and Drugs Made in America Acquisition (NASDAQ:DMAAU) are both investment offices industry companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, profitability, earnings, risk, institutional ownership and analyst recommendations.

In the previous week, Drugs Made in America Acquisition had 2 more articles in the media than Abony Acquisition Corp I. MarketBeat recorded 2 mentions for Drugs Made in America Acquisition and 0 mentions for Abony Acquisition Corp I. Abony Acquisition Corp I's average media sentiment score of 0.00 equaled Drugs Made in America Acquisition'saverage media sentiment score.

Company Overall Sentiment
Abony Acquisition Corp I Neutral
Drugs Made in America Acquisition Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abony Acquisition Corp IN/AN/AN/AN/AN/A
Drugs Made in America AcquisitionN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Abony Acquisition Corp IN/A N/A N/A
Drugs Made in America Acquisition N/A N/A N/A

Summary

Drugs Made in America Acquisition beats Abony Acquisition Corp I on 1 of the 1 factors compared between the two stocks.

How does Drugs Made in America Acquisition compare to ACP Holdings Acquisition?

Drugs Made in America Acquisition (NASDAQ:DMAAU) and ACP Holdings Acquisition (NASDAQ:ACGCU) are both investment offices industry companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, media sentiment, valuation, profitability and analyst recommendations.

In the previous week, Drugs Made in America Acquisition had 2 more articles in the media than ACP Holdings Acquisition. MarketBeat recorded 2 mentions for Drugs Made in America Acquisition and 0 mentions for ACP Holdings Acquisition. Drugs Made in America Acquisition's average media sentiment score of 0.00 equaled ACP Holdings Acquisition'saverage media sentiment score.

Company Overall Sentiment
Drugs Made in America Acquisition Neutral
ACP Holdings Acquisition Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Drugs Made in America AcquisitionN/AN/AN/AN/AN/A
ACP Holdings AcquisitionN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Drugs Made in America AcquisitionN/A N/A N/A
ACP Holdings Acquisition N/A N/A N/A

Summary

Drugs Made in America Acquisition beats ACP Holdings Acquisition on 1 of the 1 factors compared between the two stocks.

Get Drugs Made in America Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for DMAAU and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DMAAU vs. The Competition

Export
MetricDrugs Made in America AcquisitionInvestment Offices IndustryFinance SectorNASDAQ Exchange
Market CapN/A$329.65M$13.34B$11.77B
Dividend YieldN/AN/A5.80%5.26%
P/E RatioN/A1.3223.2727.07
Price / SalesN/A154.11181.7473.43
Price / CashN/A132.8220.2453.90
Price / BookN/A259.333.436.69
Net IncomeN/A-$64.15M$1.11B$332.64M
7 Day PerformanceN/A1.39%0.03%2.01%
1 Month Performance0.76%2.52%4.66%9.19%
1 Year Performance3.73%6.97%13.62%39.59%

Drugs Made in America Acquisition Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DMAAU
Drugs Made in America Acquisition
N/A$10.58
+1.4%		N/AN/A$0.00N/AN/A2
ONCHU
1RT Acquisition
N/A$10.29
+0.1%		N/AN/A$0.00N/AN/A2
ONCHW
1RT Acquisition
N/A$0.46
+4.5%		N/AN/A$0.00N/AN/A2
ASPCU
A SPAC III Acquisition
N/A$13.13
+5.0%		N/AN/A$0.00N/AN/AN/A
AACOU
Abony Acquisition Corp I
N/A$9.95
-0.3%		N/AN/A$0.00N/AN/A2

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:DMAAU) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
The $1.75T "Backdoor" ticker (NOT Starlink)
When the SpaceX IPO launches, most investors will already be too late. The real opportunity isn't the IPO itse...
Behind the Markets | Sponsoredtc pixel
URGENT: $2 Gold Stock With Major Discovery
A $2 gold stock is said to quietly control what may be the largest gold deposit in the world - worth nearly $1...
Paradigm Press | Sponsoredtc pixel